Navigating Patent Strategy and Spinouts for Medical Innovation in Wound Care
Health Unlocked: The Power of SalutogenesisJune 29, 2026x
9
00:40:4227.99 MB

Navigating Patent Strategy and Spinouts for Medical Innovation in Wound Care



The conversation focused on recent developments surrounding a newly granted device patent, often referred to as the "IBAL patent." A key theme that emerged was how this patent, covering ionic cofactor matrices and essential ion delivery for local applications, is shaping the strategy of a nonprofit organization dedicated to advancing this technology across various medical and commercial fields. The discussion explored the innovative spin-out model being used to create specialized development companies for different indications such as wound healing, psoriasis, eczema, and skin cancer, each benefiting from shared intellectual property while maintaining independence.

Several points were raised, including the reasoning behind a nonprofit holding patents, the benefits and challenges of the collaborative licensing approach, and the significant impact of recent reimbursement changes in wound care markets. Listeners will also hear about opportunities for researchers, practitioners, patients, and capital partners to participate in the mission, as well as new fundraising mechanisms designed to support the ongoing expansion and accessibility of the technology.

Timestamps:

00:00 Protecting and promoting the technology

04:56 Patent Strategy for Medical Applications

08:08 Collaborative model for IP sharing

13:08 Finding the right people for niche markets

16:31 Collaborating on IP development

18:27 Early manufacturing possibilities

21:10 Ion gel benefits and cost savings

25:23 Pricing Strategy and Profitability

29:38 Support for practitioners and researchers

33:00 Promoting the podcast and fundraiser

37:19 Nonprofit collaboration for fee savings

39:15 Discussing funding challenges


Unlocking Innovation: Patent Strategies and the Spinout Model in Healthcare

Introduction

In the latest episode of Health Unlocked, Jasen Petersen dives deep into innovative patent strategies and the unique spinout company model that could transform the delivery of healthcare solutions. By discussing the recently granted "IBAL" patent and the operational philosophy behind the Ionic Alliance Foundation, the speakers reveal how fresh thinking can accelerate impact across wound care, skin conditions, and beyond. Here are the key insights and actionable takeaways from this insightful conversation.

The IBAL Patent: Platform Innovation Over Single Product Focus

At the heart of the discussion, Jasen introduces listeners to the "IBAL" patent, a device patent describing how to prepare ionic cofactor matrices for local medical delivery. This patent has already been granted in both the UK and US, with other regions set to follow. Unlike traditional patents that protect a single product, this one covers a broader, platform-based approach. According to Jasen, the technology supports wound healing, infection control, psoriasis, eczema, and even skin cancer, designating it as a powerful foundation rather than just another medical product.

Rethinking Patent Protection for Greater Good

A distinctive point raised in the episode is how the Ionic Alliance Foundation approaches intellectual property. Rather than maximizing value extraction or restricting market access, the foundation uses its patent portfolio to prevent large pharmaceutical companies from stifling innovation. As Jasen states, the main objective is to "protect the mission" of making innovations like the IBAL platform widely accessible. This open, mission-driven mindset shifts the purpose of patents from competition to collaboration and healthcare advancement.

The Spinout Model: Specialized Focus for Broader Impact

Traditional company structures often struggle when addressing diverse markets or indications. Jasen explains why creating separate development companies for each indication makes more sense. Instead of one company spreading thin across wound care, skin cancer, and other massive markets, the foundation forms spinout entities, each licensing IP for its specific use case. This model boosts focus, agility, and expertise while enabling collaboration on data, safety, and regulatory pathways.

Balancing Collaboration and Competition with Smart Licensing

By licensing intellectual property on a per-indication basis, each spinout company benefits from the collective data and research of its peers. This approach removes direct competition and encourages participants to openly share safety and efficacy data, accelerating progress for the whole platform. Jasen details that this collaborative structure ensures better outcomes for patients while giving investors and entrepreneurs clarity over their space in the market.

Addressing Market Shifts: Wound Care Reimbursements and Opportunities

One of the pressing market shifts discussed is the change in Medicare and Medicaid reimbursement for wound care, reducing payment rates for skin substitutes. Instead of seeing this as a setback, Jasen sees a disruptive opportunity. With the IBAL technology delivering better outcomes at lower costs, there is potential for spinout companies to not only profit but also improve patient care and reduce total treatment costs. The episode highlights that not all players will welcome cost reductions, especially those benefiting from higher reimbursements, but the broader market and patients stand to gain significantly.

How Listeners and Stakeholders Can Get Involved

At the end of the episode, Jasen encourages practitioners, researchers, investors, and even patients to engage in this evolving movement. Practitioners can trial the cosmetic versions with patients, researchers are invited to collaborate on further studies, and capital partners can help fund new development companies or participate via innovative decentralized science models.

Conclusion: Accelerating Health Innovation Together

The Health Unlocked episode showcases how a thoughtful patent strategy combined with an innovative spinout model can drive large-scale change in healthcare. By prioritizing mission over profit, fostering transparent collaboration, and creating opportunities for focused spinout enterprises, the Ionic Alliance Foundation provides a roadmap for sustainable, impactful innovation. To learn more or participate, share the episode, reach out to the foundation, or simply keep the conversation going within your community.

For complete details and opportunities to engage, be sure to listen to the full episode of Health Unlocked.


“Disclaimer: Informational only. Not medical advice. Consult your doctor for guidance.”

Show Website - https://powerofsalutogenesis.com/

Ionic Alliance Foundation Website - https://iaf.care/

Jasen Petersen's LinkedIn - https://www.linkedin.com/in/jasenepetersen/

TopHealth Media Website - https://tophealth.care/